Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Older adults
2023
Clear all
Type of publications
Systematic reviews (SYSVAC)
(25)
Topics
Available to download in languages
Regions
Africa
(1)
Eastern Mediterranean
(1)
Europe
(1)
Countries
Diseases
COVID-19
(24)
Human papillomavirus (HPV)
(1)
Herpes zoster
(5)
Influenza
(5)
Pneumococcal disease
(2)
Vaccine topics
Efficacy/effectiveness
(25)
Acceptance
(7)
Coverage
(1)
Ethical issues
(2)
Safety
(34)
Target population
Older adults
(25)
Adolescents
(17)
Adults
(33)
All age groups
(38)
Children
(6)
Healthcare workers
(2)
Newborn
(3)
Pregnant women
(6)
Publication date
2023
(25)
2022
(67)
2021
(27)
2020
(3)
2018
(1)
2014
(1)
25 results found
2023
∙
Xu, K. Wang, Z. Qin, M. Gao, Y. Luo, N. Xie, W. Zou, Y. Wang, J. Ma, X.
A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
2023
∙
Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
2023
∙
Liatsou, E. Ntanasis-Stathopoulos, I. Lykos, S. Ntanasis-Stathopoulos, A. Gavriatopoulou, M. Psaltopoulou, T. Sergentanis, T. N. Terpos, E.
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
2023
∙
Wang, X. Haeussler, K. Spellman, A. Phillips, L. E. Ramiller, A. Bausch-Jurken, M. T. Sharma, P. Krivelyova, A. Vats, S. Van de Velde, N.
Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework
2023
∙
Ruiz, J. I. Lopez-Olivo, M. A. Geng, Y. Suarez-Almazor, M. E.
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
2023
∙
Wankhede, D. Grover, S. Hofman, P.
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
2023
∙
Zhang, J. Yang, W. Huang, F. Zhang, K.
Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis
2023
∙
Hausinger, R. I. Bachmann, Q. Crone-Rawe, T. Hannane, N. Monsef, I. Haller, B. Heemann, U. Skoetz, N. Kreuzberger, N. Schmaderer, C.
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review
2023
∙
Law, M. Ho, S. S. H. Tsang, G. K. C. Ho, C. M. Y. Kwan, C. M. Yan, V. K. C. Yiu, H. H. E. Lai, F. T. T. Wong, I. C. K. Chan, E. W. Y.
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
2023
∙
Joudeh, A. I. Lutf, A. Q. Mahdi, S. Tran, G.
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register